Cunnington M - Search Results

1

Risk of ischaemic cardiovascular events from selective cyclooxygenase-2 inhibitors in osteoarthritis.

Cunnington M, Webb D, Qizilbash N, Blum D, Mander A, Funk MJ, Weil J. Cunnington M, et al. Pharmacoepidemiol Drug Saf. 2008 Jun;17(6):601-8. doi: 10.1002/pds.1590. Pharmacoepidemiol Drug Saf. 2008. PMID: 18383442

2

Data resources for investigating drug exposure during pregnancy and associated outcomes: the General Practice Research Database (GPRD) as an alternative to pregnancy registries.

Charlton RA, Cunnington MC, de Vries CS, Weil JG. Charlton RA, et al. Drug Saf. 2008;31(1):39-51. doi: 10.2165/00002018-200831010-00004. Drug Saf. 2008. PMID: 18095745 Review.

3

Risk factors for antiepileptic drug regimen change in patients with newly diagnosed epilepsy.

Cunnington MC, Webb DJ, Irizarry MC, Manjunath R. Cunnington MC, et al. Epilepsy Behav. 2011 Jun;21(2):168-72. doi: 10.1016/j.yebeh.2011.03.017. Epub 2011 Apr 30. Epilepsy Behav. 2011. PMID: 21531633

4

Comparing the General Practice Research Database and the UK Epilepsy and Pregnancy Register as tools for postmarketing teratogen surveillance: anticonvulsants and the risk of major congenital malformations.

Charlton RA, Weil JG, Cunnington MC, Ray S, de Vries CS. Charlton RA, et al. Drug Saf. 2011 Feb 1;34(2):157-71. doi: 10.2165/11584970-000000000-00000. Drug Saf. 2011. PMID: 21247222

5

Identifying major congenital malformations in the UK General Practice Research Database (GPRD): a study reporting on the sensitivity and added value of photocopied medical records and free text in the GPRD.

Charlton RA, Weil JG, Cunnington MC, de Vries CS. Charlton RA, et al. Drug Saf. 2010 Sep 1;33(9):741-50. doi: 10.2165/11536820-000000000-00000. Drug Saf. 2010. PMID: 20701407

6

Advantages and problems with pregnancy registries: observations and surprises throughout the life of the International Lamotrigine Pregnancy Registry.

Sinclair S, Cunnington M, Messenheimer J, Weil J, Cragan J, Lowensohn R, Yerby M, Tennis P. Sinclair S, et al. Among authors: cunnington m. Pharmacoepidemiol Drug Saf. 2014 Aug;23(8):779-86. doi: 10.1002/pds.3659. Epub 2014 Jun 27. Pharmacoepidemiol Drug Saf. 2014. PMID: 24974947 Free PMC article. Review.

7

Final results from 18 years of the International Lamotrigine Pregnancy Registry.

Cunnington MC, Weil JG, Messenheimer JA, Ferber S, Yerby M, Tennis P. Cunnington MC, et al. Neurology. 2011 May 24;76(21):1817-23. doi: 10.1212/WNL.0b013e31821ccd18. Neurology. 2011. PMID: 21606453

8

Regarding the need, or lack thereof, of a comparator group for pregnancy registries.

Charlton R, Cunnington M, Weil J, de Vries C. Charlton R, et al. Among authors: cunnington m. Birth Defects Res A Clin Mol Teratol. 2009 Sep;85(9):808; author reply 809-10. doi: 10.1002/bdra.20598. Birth Defects Res A Clin Mol Teratol. 2009. PMID: 19551713 No abstract available.

9

Lamotrigine and the risk of malformations in pregnancy.

Cunnington M, Tennis P; International Lamotrigine Pregnancy Registry Scientific Advisory Committee. Cunnington M, et al. Neurology. 2005 Mar 22;64(6):955-60. doi: 10.1212/01.WNL.0000154515.94346.89. Neurology. 2005. PMID: 15781807

10

Pregnancy registries: strengths, weaknesses, and bias interpretation of pregnancy registry data.

Cunnington M, Messenheimer J. Cunnington M, et al. Int Rev Neurobiol. 2008;83:283-304. doi: 10.1016/S0074-7742(08)00017-2. Int Rev Neurobiol. 2008. PMID: 18929089 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

86 results

Search Page

Filters